In accordance with standard industry practice, BioRestorative plans to wait to provide investors with further updates on the Type B meeting until such time that it has received and reviewed the ...
uniQure expects to receive final minutes within 30 days of the meeting and plans to urgently interact with the FDA to find a path forward for the timely accelerated approval of AMT-130.
Pierre Fabre Pharmaceuticals Inc. (PFP) announces the transfer of the Biologics License Application (BLA) for tabelecleucel ...
Q3 2025 Management View CEO Matthew Kapusta reported, "in the third quarter, we announced positive top line data from our ...
US biopharma firm Viridian Therapeutics today announced the successful submission of its biologics license application (BLA) to the US Food and Drug Administration (FDA) for veligrotug, the company’s ...
Savara advances BLA plans with strong molgramostim data, large aPAP market potential, and a reinforced cash position. Find ...
Outlook Therapeutics Inc. (NASDAQ:OTLK) surged 17.2% in premarket trading Thursday after announcing that the U.S. Food and ...
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...
The Barbados Licensing Authority (BLA) yesterday issued a statement in response to public claims made by one of the ...
Motorists in northern Barbados now have easier access to vehicle registration services, following the expansion of operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback